Domain's Portfolio Companies are Improving Lives through Medical Innovation
January 25, 2016Domain's Top Portfolio Company Stories 2015
January 24, 2016A number of our portfolio companies made headlines this year. Here a just a few of those stories.
More »
Domain's Portfolio Companies Had 17 Product Milestones 2015
January 24, 2016Domain Associates prides itself on its track record of supporting companies that bring products to the global market to help patients around the world.
More »
The Economist: RNAi Therapies Still Hold Great Promise
October 30, 2015An article in The Economist featured the rise, fall, and hopeful future of companies developing RNA interference (RNAi)-based therapeutics.
More »
Fractyl Laboratories Named to Fierce 15 List by FierceMedicalDevices
October 14, 2015This year’s Fierce 15 list includes Domain portfolio company, Fractyl Laboratories, which has developed a unique device-based endoscopic procedure that alters the body’s ability to process sugar and dramatically improve glycemic control for patients with type 2 diabetes.
More »